Factor V Leiden and Thrombophilia
- 18 May 1995
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (20), 1381-1384
- https://doi.org/10.1056/nejm199505183322014
Abstract
Greengard et al. (Dec. 8 issue)1 describe siblings, from a symptomatic family, who were homozygous for the arginine → glutamine mutation at position 506 in the factor V gene. On the basis of this report and others,2-4 one can estimate that there are hundreds of thousands of homozygotes in Europe and the United States. Many of them probably come from families in which the heterozygous state is asymptomatic, since the mutation is very common in the general population.1-4 At present, it is not known whether homozygous members of such families have an increased risk of thrombosis.Keywords
This publication has 8 references indexed in Scilit:
- Factor V Leiden -- An Unselfish Gene?New England Journal of Medicine, 1994
- Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor VNew England Journal of Medicine, 1994
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.Journal of Clinical Investigation, 1994
- Bad blood by mutationNature, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993